Effect of glargine insulin delivery method (pen-device vs. vial-syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes

January 15, 2014

Stacey A. Seggelke et al. Endocrine Practice. Doi: 10.4158/EP13404.OR

The objective of this study was to evaluate the effects of 2 glargine insulin delivery methods (pen vs. vial-syringes) on glycemic control and patient preferences. Thirty-one patients discharged from the hospital were recruited for this study.

It was found that patients switching to glargine pen achieved lower HbA1c at 6 months of follow-up. Patients in both groups overwhelmingly preferred glargine pens over vial-syringes.

Article information
Endocrine Practice
Jan 15, 2014
Free HCP newsletter
Join the newsletter
Free weekly news
Latest diabetes healthcare news direct to your inbox.
NHS employee:
Latest forum posts
The latest forum threads from the Ask a Question forum.
Healthcare Search